Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
41,452,380
-
Share change
-
+2,250,967
-
Total reported value
-
$326,223,019
-
Price per share
-
$7.87
-
Number of holders
-
87
-
Value change
-
+$18,161,948
-
Number of buys
-
37
-
Number of sells
-
39
Institutional Holders of AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) as of Q4 2020
As of 31 Dec 2020,
AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,452,380 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Point72 Asset Management, L.P., Bain Capital Life Sciences Investors, LLC, PICTET ASSET MANAGEMENT LTD, Nantahala Capital Management, LLC, VANGUARD GROUP INC, and Aisling Capital Management LP.
This page lists
87
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.